A DNA-derived phage nose using machine learning and artificial neural processing for diagnosing lung cancer
2021 · Biosensors and Bioelectronics · 33 citations
https://doi.org/10.1016/j.bios.2021.113567
S
Seong Hoon Yoon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
1.0K
Citations
18
h-index
32
i10-index
Seong Hoon Yoon is an academic researcher from Pusan National University Yangsan Hospital. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 18, co-authored 85 publications.
ORCID: 0000-0002-2075-4702Papers by this author
worksEfficacy and safety of docetaxel plus oxaliplatin as a first‐line chemotherapy in patients with advanced or metastatic non‐small cell lung cancer
2014 · Thoracic Cancer · 6 citations
https://doi.org/10.1111/1759-7714.12123
Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial
2025 · Integrative Cancer Therapies · 5 citations
https://doi.org/10.1177/15347354251319339
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations
2024 · Integrative Cancer Therapies · 3 citations
https://doi.org/10.1177/15347354241268231
A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
2020 · Medicine · 1 citations
https://doi.org/10.1097/md.0000000000023455
Additional file 2 of MHY4571, a novel diarylcyclohexanone derivative, exerts anti-cancer activity by regulating the PKA-cAMP-response element-binding protein pathway in squamous cell lung cancer
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21301400
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat